[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606424":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":62,"collaborators":64,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":19,"eligibilityCriteria":76,"healthyVolunteers":72,"sex":77,"minAge":78,"maxAge":19,"enrollmentInfo":79,"targetDuration":19,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":90,"overallStatus":33,"whyStopped":19,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Wake Forest University Health Sciences","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Participants 65 years or older with active cancer diagnosis and planned chemotherapy","EXPERIMENTAL","Participants aged 65 or older with an active cancer diagnosis who are planned to receive chemotherapy and are eFI pre-frail or frail. Participants will be provided with results and education regarding baseline assessments and offered referrals for supportive care interventions to decrease chemotherapy toxicity",[13],"Other: Supportive Care",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Supportive Care","Geriatric assessment (GA) -guided supportive care and weekly Patient Reported Outcomes (PRO) symptom assessment",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Heidi Klepin, MD","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},"James Morgan","CONTACT","336-702-4491","james.morgan@advocatehealth.org",[31,50],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Levine Cancer Institute","RECRUITING","Charlotte","North Carolina","28204","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-80.84313,35.22709,{"lat":43,"lon":42},[46],{"name":47,"role":27,"phone":48,"phoneExt":19,"email":49},"Kunal Kadakia, MD","980-442-5905","kunal.kadakia@advocatehealth.org",{"facility":51,"status":33,"city":52,"state":35,"zip":53,"country":37,"countryCode":38,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","Winston-Salem","27157",{"type":40,"coordinates":55},[56,57],-80.24422,36.09986,{"lat":57,"lon":56},[60,61],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},{"name":22,"role":23,"phone":19,"phoneExt":19,"email":19},{"type":63,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[65,67],{"name":66,"class":6},"Atrium Health Wake Forest Baptist",{"name":68,"class":69},"National Cancer Institute (NCI)","NIH","100606424","resilience-enhancement-using-electronic-frailty-index-directed-care-pathway-100606424",false,"NCT07175376","Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway","Resilience Enhancement Utilizing an Electronic Frailty Index-Directed Care Pathway for Older Adults Receiving Chemotherapy (RESILIENCE-e): A Prospective Single-Arm Interventional Study","Inclusion Criteria:\n\nPatients with cancer:\n\n* Ability to understand and willingness to sign an IRB-approved informed consent\n* Age ≥ 65 years at the time of enrollment.\n* Planned to initiate an outpatient chemotherapy regimen (including myelosuppressive biologic\u002Fimmune therapies) for cancer treatment (any type or stage), either as an initial therapy or as a new line of therapy, with curative or palliative intent.\n* eFI pre-frail or frail status (available in EHR; defined as eFI \\> 0.10) within 30 days before enrollment.\n* Ability to read and understand the English language\n\nProviders:\n\n* Treating medical oncologist of at least one patient participant who enrolled on to the study and completed baseline assessment.\n\nExclusion Criteria:\n\nPatients:\n\n* Documented physical or psychological comorbidity that would limit participant's ability to understand or comply with study procedures for the entire length of the study per the enrolling investigator.\n* Chemotherapy planned at a facility outside the Atrium Health system.\n* Currently receiving chemotherapy (defined as planned to continue an on-going treatment rather than starting a new regimen).","ALL","65 Years",{"count":80,"type":81},32,"ESTIMATED","INTERVENTIONAL",[84],"NA","The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.",[87,88,89],"Cancer","Frail","Chemotherapy",[87,91,92],"Frailty Index","eFI score","2026-07-01",{"date":95,"type":96},"2026-07-02","ACTUAL",{"date":98,"type":96},"2026-03-16",{"date":100,"type":81},"2027-05",{"name":5,"class":6},2]